Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: A double-blind, randomized, controlled study

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 3, 2002, Pages 587-593

  Marteau, P ^a   Cuillerier, E ^a   Meance, S ^b   Gerhardt, M F ^c   Myara, A ^c   Bouvier, M ^d   Bouley, C ^b   Tondu, F ^b   Bommelaer, G ^e   Grimaud, J C ^d  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b DANONE RESEARCH   (France)

^c SAINT JOSEPH HOSPITAL   (France)

^d HÔPITAL NORD   (France)

^e UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID;

ADULT; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; CLINICAL TRIAL; COLON; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; INTESTINE TRANSIT TIME; NORMAL HUMAN; PH MEASUREMENT; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIGMOID;

ADULT; BIFIDOBACTERIUM; BIOMASS; CROSS-OVER STUDIES; DIET; DOUBLE-BLIND METHOD; FECES; FEMALE; FERMENTATION; GASTROINTESTINAL TRANSIT; HUMANS; YOGURT;

EID: 0036185671     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01188.x     Document Type: Article

References (27)

1. Functional food science and gastrointestinal physiology and function
2. Protection from gastrointestinal diseases using probiotics
3. Bifidobacteria and probiotic action
4. Survie dans l'intestin grėle de Lactobacillus acidophilus et Bifidobacterium sp. ingérés dans un lait fermenté: Une base rationnelle pour l'utilisation des probiotiques chez l'homme
5. Fecal recovery in man of viable Bifidobacterium sp. ingested in a fermented milk
6. Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: An in vivo study using intestinal perfusion
7. Bifidobacterium from fermented milks: Survival during gastric transit
8. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in man
9. A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces
10. Effect of propionibacteria supplementation on fecal bifidobacteria and segmental colonic transit time in healthy human subjects
11. Effects of consumption of a milk fermented with the probiotic strain Bifidobacterium animalis DN-173 010 on colonic transit times in healthy humans
12. Screening of lactic acid bacteria for bile salt hydrolase activity
13. Bifidobacteria and probiotic effects: Action of Bifidobacterium species on conjugated bile salts
14. Bile acid transformation by the intestinal flora and cholesterol saturation in bile. Effect of Streptococcus faecium administration
15. Determination of total and segmental colonic transit time in constipated patients
16. The microbial contribution to human faecal mass
17. General methods for the analysis of metabolic profiles of bile acids and related compounds in feces
18. A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children
19. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis
20. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus
21. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity
22. Faecal bile acids and colorectal cell proliferation
23. Toxicity of bile acids to colon cancer cell lines
24. Colonic mucosal proliferation is related to serum deoxycholic acid levels
25. The metabolic consequences of slow colonic transit
26. Anaerobic transformation of quercetin-3-glucoside by bacteria from the human intestinal tract
27. Effect of phloroglucinol on rectosigmoid motility stimulated by a test meal. Study in patients with irritable bowel syndrome